Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Vaccines for the Icelandic Vaccination Programme. Dps

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Lacosamide (Atc Code According to Who: N03ax18)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Lacosamide (atc Code According to Who: N03ax18)

Supply of Cleaning Products, Hygiene and Drugstore Items for the Pays De Loire Regional Grouping (6 Categories)

Ultrasound Equipment

Degree Non-Excl. am Discount Agreements According to Section 130A Paragraph 8 Sgb V by Means of a So-Called Open-House Model for the Active Substance Tiotropium Bromide, Administration of Inhalation Solution (Atc Code Who: R03bb04)

Completion Non-exkl. Am Discount Agreements According to § 130a Paragraph 8 Sgb V by Means of a So-called Open-house Model to the Active Ingredient Tiiotropium Bromide, Presentation Inhalation Solution (atc Code Who: R03bb04)